Purus Labs Recalls MyoWhey due to Undeclared Allergens
PLANO, Texas, Sept. 20, 2018 /PRNewswire/ -- Purus Labs, Inc is recalling MyoWhey Chocolate Cookie Crunch, because it may contain undeclared milk and soy. This only effects products with Lot number PL: 0100518 Exp: 04/2020. People who have an allergy or severe sensitivity to milk and soy run the risk of serious or life-threatening allergic reaction if they consume these products.
MyoWhey was distributed through online mail orders to AR, TX, FL, MI, VA, and OK. MyoWhey was available through retail stores in TX, CA, OK, CO, and MO. MyoWhey was also available internationally in Chile and UAE.
MyoWhey Chocolate Cookie Crunch is sold in a white plastic container with a net weight of 5 pounds or 2.26 kg. Affected products can be identified by lot number PL: 0100518 Exp: 04/2020 which is printed on the bottom of the container.
No illnesses have been reported to date.
The recall was initiated after a routine inspection by the Texas Department of State Health Services determined that the product had been distributed without proper allergen labeling for milk and soy.
Please discard the product if you are allergic to any of the undeclared allergens. Consumers who have purchased Purus Labs MyoWhey Chocolate Cookie Crunch or have further questions regarding this recall are urged to contact Purus Labs at 214-221-1813.
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that, further...
Prescient Healthcare Group, a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors ? Dr. Luke Solon and Debbie Allman ? to help shape and drive Prescient's global mission....
Snufff, the innovative nasal inhaler, emerges onto the wellness and lifestyle scene, offering a refreshing blend of enjoyment and health benefits. Crafted in the vibrant heart of Singapore, Snufff aims to revolutionize the way we approach personal...
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") , a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the...
MGI Tech, a company committed to building core tools and technology to lead life science, is proud to announce that its DNBSEQ-T20x2* gene sequencer has been recognized with a Gold Edison Award in the "Health, Medical & Biotech" category....
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company sought an extension of its previously announced stay of proceedings ("Stay") under the Companies' Creditors Arrangement Act (the "CCAA") at a hearing before the Ontario...
